TINA POWELL: Open Payments
NPI 1770509028 · RIDLEY PARK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,888 in 121 payments from 40 companies in 2025. Trend: 2023 $331 · 2024 $3,417 · 2025 $2,888
Food & beverage: $2,833Education: $54
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $295 |
| Daiichi Sankyo Inc. | 12 | $271 |
| Janssen Biotech, Inc. | 9 | $244 |
| Novartis Pharmaceuticals Corporation | 10 | $240 |
| ABBVIE INC. | 8 | $174 |
| Gilead Sciences, Inc. | 6 | $128 |
| Astellas Pharma US Inc | 1 | $123 |
| Incyte Corporation | 4 | $100 |
| Eisai Inc. | 4 | $95 |
| Merck Sharp & Dohme LLC | 4 | $86 |
Products named: Enhertu, KISQALI, Vyloy, Trodelvy, Lenvima, LYNPARZA, Epkinly, KEYTRUDA.
Industry payments across PA — which companies pay providers there.
